Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.7703
+0.00340.44%
Post-market: 0.80980.0395+5.13%16:50 EDT
Volume:994.49K
Turnover:780.70K
Market Cap:64.53M
PE:-0.26
High:0.8099
Open:0.7900
Low:0.7696
Close:0.7669
Loading ...

BRIEF-Sutro Biopharma Announces Initiation Of The Registration-Enabling REFRαME-P1 Trial With Luvelta For Pediatric Patients With CBF/GLIS AML

Reuters
·
01 Nov 2024

Sutro Biopharma Announces Initiation of the Registration-Enabling RefrΑMe-P1 Trial With Luvelta for Pediatric Patients With Cbf/Glis Aml

THOMSON REUTERS
·
01 Nov 2024

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

GlobeNewswire
·
01 Nov 2024

Singapore publishes national anti-money laundering strategy

Douglas Toh
·
30 Oct 2024

Truist Financial Reaffirms Their Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
21 Oct 2024

Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago

Simply Wall St.
·
20 Oct 2024

Sutro Biopharma Price Target Maintained With a $11.00/Share by Piper Sandler

Dow Jones
·
12 Oct 2024

Sutro Biopharma (STRO) Gets a Buy from Wedbush

TIPRANKS
·
11 Oct 2024

Revenues Working Against Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Following 25% Dive

Simply Wall St.
·
11 Oct 2024

Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Oct 2024

Piper Sandler Sticks to Its Buy Rating for Sutro Biopharma (STRO)

TIPRANKS
·
11 Oct 2024

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

GlobeNewswire
·
11 Oct 2024

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 Sep 2024

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
21 Sep 2024